Gene Techno Science

About:

Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan.

Top Investors: Mizuho Capital, DBJ Capital, TAL, Nippon Venture Capital, Daiwa Corporate Investment

Description:

Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan. The company develops drugs for the treatment of immunological, cardiovascular, ophthalmic, infectious, and renal diseases as well as oncology drugs. It also offers Filgrastim for the treatment of cancer. Gene Techno Science was founded in 2001 and is headquartered in Sapporo, Japan.

Total Funding Amount:

2.71B JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2001-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2013-02-28

IPO Status:

Public

Industries: